Wei Zeng

459 total citations
34 papers, 318 citations indexed

About

Wei Zeng is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wei Zeng has authored 34 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wei Zeng's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Wei Zeng is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Wei Zeng collaborates with scholars based in China, United States and Australia. Wei Zeng's co-authors include Zhangxin Chen, Yu Hu, Bo Chen, Yuanyuan Lin, Yuanzeng Min, Ying Liu, Ruijie Huang, Jingling Liu, Wei Wang and Liang Tang and has published in prestigious journals such as PLoS ONE, Biomaterials and Scientific Reports.

In The Last Decade

Wei Zeng

31 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Zeng China 11 134 53 39 37 33 34 318
Branislava Dobutović Serbia 11 103 0.8× 36 0.7× 32 0.8× 13 0.4× 19 0.6× 14 338
Emilia Sokołowska Poland 9 226 1.7× 38 0.7× 17 0.4× 50 1.4× 27 0.8× 17 540
Sascha Meyer dos Santos Germany 11 94 0.7× 63 1.2× 18 0.5× 28 0.8× 9 0.3× 16 352
Elisabetta Lombardi Italy 10 97 0.7× 54 1.0× 24 0.6× 8 0.2× 25 0.8× 16 440
Shuo Miao China 12 232 1.7× 35 0.7× 122 3.1× 7 0.2× 21 0.6× 24 410
Maria do Céu Monteiro Portugal 9 118 0.9× 42 0.8× 16 0.4× 7 0.2× 8 0.2× 27 356
Chengcheng Xu China 9 126 0.9× 11 0.2× 37 0.9× 8 0.2× 12 0.4× 20 311
Paolo Alberti Italy 10 64 0.5× 36 0.7× 24 0.6× 18 0.5× 3 0.1× 15 335
Hongfang Lu Canada 6 196 1.5× 25 0.5× 23 0.6× 14 0.4× 56 1.7× 7 455
Hidekazu Shimizu Japan 7 195 1.5× 22 0.4× 21 0.5× 10 0.3× 5 0.2× 10 314

Countries citing papers authored by Wei Zeng

Since Specialization
Citations

This map shows the geographic impact of Wei Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zeng more than expected).

Fields of papers citing papers by Wei Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zeng. The network helps show where Wei Zeng may publish in the future.

Co-authorship network of co-authors of Wei Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Zeng. A scholar is included among the top collaborators of Wei Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Zeng. Wei Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niu, Li, et al.. (2024). Nuclear translocation of STAT5 initiates iron overload in huntington’s disease by up-regulating IRP1 expression. Metabolic Brain Disease. 39(4). 559–567. 1 indexed citations
2.
Yang, Yujie, Wei Zeng, Jinhua Zhou, et al.. (2024). Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients. Scientific Reports. 14(1). 19269–19269. 3 indexed citations
3.
Wang, Jixin, Jixin Wang, Wei Zeng, et al.. (2024). Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice. British Journal of Pharmacology. 182(5). 1143–1163.
4.
Ye, Shenghai, Wei Zeng, Rongrong Zhai, et al.. (2024). Mutation of Short Panicle Gene 3 Caused Shorter Panicle Through Auxin and Cytokinin Pathway in Rice. Journal of Plant Growth Regulation. 44(2). 988–998.
5.
Li, Jiale, et al.. (2024). The landscape of extracellular vesicles combined with intranasal delivery towards brain diseases. Nano Today. 55. 102169–102169. 9 indexed citations
6.
Wang, Yongjin, Yandan Wang, Qayyum Shehzad, et al.. (2023). Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition. 64(26). 1–28. 53 indexed citations
7.
Chen, Bo, Ruijie Huang, Wei Zeng, Wei Wang, & Yuanzeng Min. (2023). Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect. Biomaterials. 305. 122434–122434. 23 indexed citations
8.
Niu, Li, et al.. (2021). HPV infection upregulates the expression of ZNT-1 in condyloma acuminatum. European Journal of Histochemistry. 65(2). 2 indexed citations
9.
Zeng, Wei, Jingling Liu, Xuewen Zheng, et al.. (2017). Peroxiredoxin-1 promotes cell proliferation and metastasis through enhancing Akt/mTOR in human osteosarcoma cells. Oncotarget. 9(9). 8290–8302. 22 indexed citations
10.
Zeng, Wei, Bei Hu, Liang Tang, et al.. (2017). Recurrent mutations in aSERPINC1hotspot associate with venous thrombosis without apparent antithrombin deficiency. Oncotarget. 8(48). 84417–84425. 5 indexed citations
11.
Zeng, Wei, Tao Xiao, Huanhuan Liu, et al.. (2017). Inhibiting ROS-TFEB-Dependent Autophagy Enhances Salidroside-Induced Apoptosis in Human Chondrosarcoma Cells. Cellular Physiology and Biochemistry. 43(4). 1487–1502. 27 indexed citations
12.
Wang, Qingyun, Bei Hu, Hui Liu, et al.. (2016). A genetic analysis of 23 Chinese patients with hemophilia B. Scientific Reports. 6(1). 25024–25024. 1 indexed citations
13.
Liu, Hui, Huafang Wang, Zhipeng Cheng, et al.. (2015). Phenotypic and genotypic characterization of four factor VII deficiency patients from central China. Blood Coagulation & Fibrinolysis. 26(4). 408–413. 5 indexed citations
14.
Li, Yiqing, Qingyun Wang, Hui Liu, et al.. (2014). Genetic analysis should be included in clinical practice when screening for antithrombin deficiency. Thrombosis and Haemostasis. 113(2). 262–271. 22 indexed citations
15.
Xiang, Lan, et al.. (2013). Effects of Lamivudine on Outcome after Initial Treatment for Hepatocellular Carcinoma: A Meta-Analysis. Journal of Gastroenterology and Hepatology Research. 2(12). 924–928. 1 indexed citations
16.
Ai, Lisha, Chunyan Sun, Lu Zhang, et al.. (2012). Inhibition of BDNF in Multiple Myeloma Blocks Osteoclastogenesis via Down-Regulated Stroma-Derived RANKL Expression Both In Vitro and In Vivo. PLoS ONE. 7(10). e46287–e46287. 36 indexed citations
17.
Zeng, Wei. (2010). The Prevalence of Hypertension Among Middle-Aged and Elderly People in Chengdu. 1 indexed citations
18.
Liu, Ya, Bin Huang, Xiujun Li, et al.. (2009). Prevalence of the glycometabolic abnormality among resident people aged 40–79 years old in Chengdu area. 1(4). 282–285. 1 indexed citations
19.
Yi, Zhengjun, et al.. (2006). [Expression of human granulysin in murine macrophages and its effects on cell damage and apoptosis].. PubMed. 22(1). 14–7. 1 indexed citations
20.
Yang, Falong, et al.. (2006). [Establishing a real-time PCR assay for anatid herpesvirus 1].. PubMed. 37(5). 801–3, 813. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026